Former FDA chief: Ultraprocessed foods are ‘addictive’ like drugs
Related:
What the top doctor did to stop eating junk (archived)
Read More »Tag: Ozempic
A study linking popular weight loss drug to suicide risk again raises long-standing safety questions
Editor’s Note: If you or someone you know is struggling with suicidal thoughts or mental health matters, please call the 988 Suicide & Crisis Lifeline by dialing 988 to connect with a trained counselor, or visit the 988 Lifeline website.
People taking semaglutide, the popular medication for diabetes and weight loss, are more likely to report having thoughts of suicide compared with those taking other drugs, according to a new study of an international drug safety database. But the finding is the latest see-saw of scientific evidence on the risk of depression and suicide tied to the popular medications — and critics say evidence that the drugs cause problems with mood is limited.
A study linking popular weight loss drug to suicide risk again raises long-standing safety questions
Related:
Ian Douglas, London School of Hygiene & Tropical Medicine:
I am an epidemiologist, currently funded by GlaxoSmithKline. I initially studied physiology at BSc and PhD level in Manchester. Since then, I spent several years at the UK Medicines & Healthcare Products Regulatory Agency and in the pharmaceutical industry investigating adverse effects of drugs – both in clinical trials and post-marketing. I completed the MSc in epidemiology at LSHTM in 2005.
Previously:
Medicare to cover obesity drugs, but not for weight loss
Wegovy, Rybelsus, and Ozempic, are the different brand names for Semaglutide. They have a black box warning for Medullary thyroid cancer.* 🤦🏼♀️
Related:
Everything We Learned From Oprah’s Weight Loss Special
Using Mounjaro may increase your risk of developing thyroid cancer.
Everything We Learned From Oprah’s Weight Loss Special
Everything We Learned From Oprah’s Weight Loss Special
Related:
Using Mounjaro may increase your risk of developing thyroid cancer.
Medicare to cover obesity drugs, but not for weight loss
Medicare to cover obesity drugs, but not for weight loss
“CMS has issued guidance to Medicare Part D plans stating that anti-obesity medications (AOMs) that receive FDA approval for an additional medically accepted indication can be considered a Part D drug for that specific use,” the spokesperson added, specifying that drugs that are FDA-approved for only weight loss do not fall under this consideration.
Wegovy, Rybelsus, and Ozempic, are the different brand names for Semaglutide. They have a black box warning for Medullary thyroid cancer.* 🤦🏼♀️
Related:
‘There’s no way that patients are going to be able to afford that.’ Why aren’t new drugs that can help you lose weight more widely used?
A pair of new drugs offer something many Americans desperately want: a way to lose weight.
‘There’s no way that patients are going to be able to afford that.’ Why aren’t new drugs that can help you lose weight more widely used?
“Ten years ago, policymakers would come out and say, ‘Fat people need to eat less and move more.’” – majority of people still feel this way, unfortunately. Most of them don’t know how hard it is to lose weight or if they have, they don’t understand that one weight loss plan may not work for another. Same way it is with medical treatments. One size fits all doesn’t fit all!
Ms. Cat’s Chronicles 